Celtic Pharma

Celtic Pharma Management L.P. is a venture capital firm based in Hamilton, Bermuda, with additional offices in New York City and London. The firm specializes in the biotechnology and pharmaceutical sectors, focusing on acquiring direct ownership or controlling stakes in pharmaceutical products that are in the late stages of clinical and regulatory development. Celtic Pharma is dedicated to funding and actively managing these investments through the final two to four years of clinical development and regulatory approval, which includes establishing manufacturing arrangements and preparing for market launch. By targeting novel and commercially attractive products, Celtic Pharma aims to support the advancement of innovative healthcare solutions.

Michael Earl

Partner

George Iliffe

Director

Alexandre J. L'Heureux

Investment Professional

John Mayo

Managing General Partner

Bob Milsted

Managing Director

Stephen Parker

Partner

3 past transactions

Cantab Biopharmaceuticals

Venture Round in 2010
Cantab Biopharmaceuticals Limited, a biopharmaceutical company, discovers and develops biosuperior protein therapeutics. The company focuses on hematology and infectious diseases. Biopharmaceuticals Limited was formerly known as Cambridge Biomanufacturing Limited. The company was incorporated in 2006 and is based in Cambridge, United Kingdom.

Novacta Biosystems

Venture Round in 2009
Leveraging the extensive knowledge of GSK's Biotransformation and Natural Products scientific team, Novacta Biosystems Ltd was founded in 2003. In the following 5 years, Novacta successfully adopted a dual business model, whereby it developed a biocatalysis and microbial pathway engineering service business, that supported its efforts to build an infectious disease therapeutic pipeline.

Xenova

Acquisition in 2005
Xenova publicly quoted biotechnology company focused on the development of novel drugs to treat cancer and addiction.